BioXcel Therapeutics, Inc. Common Stock (BTAI)
BioXcel Therapeutics, Inc. (BTAI) is a biotechnology company focused on the development and commercialization of artificial intelligence-driven therapies for neuroscience and immuno-oncology indications. The company utilizes its proprietary platform to identify and develop innovative drug candidates, aiming to address unmet medical needs in areas such as acute neuropsychiatric disorders and cancer.
Company News
BioXcel Therapeutics announced it has regained compliance with Nasdaq's market value listing requirements after previously being notified of non-compliance in March 2025.
Three stocks - BioXcel Therapeutics, Telos, and Jumia - have shown significant momentum gains, with substantial price increases and strong performance in Benzinga's momentum rankings over the past week.
Penny stocks to watch this week. The post 5 Most Active Penny Stocks Today & Why They’re Moving Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Audit findings support application for approval of treatment for Alzheimer's-related agitation, company says
The company's co-founder is leaving, and layoffs are coming.